EP1937300A4 - Méthodes et compositions pour produire et contrôler le profil effecteur de lymphocytes t par chargement et activation simultanés de sous-ensembles sélectionnés de cellules présentatrices d'antigène - Google Patents

Méthodes et compositions pour produire et contrôler le profil effecteur de lymphocytes t par chargement et activation simultanés de sous-ensembles sélectionnés de cellules présentatrices d'antigène

Info

Publication number
EP1937300A4
EP1937300A4 EP06801942A EP06801942A EP1937300A4 EP 1937300 A4 EP1937300 A4 EP 1937300A4 EP 06801942 A EP06801942 A EP 06801942A EP 06801942 A EP06801942 A EP 06801942A EP 1937300 A4 EP1937300 A4 EP 1937300A4
Authority
EP
European Patent Office
Prior art keywords
cells
antigen
activation
compositions
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06801942A
Other languages
German (de)
English (en)
Other versions
EP1937300A2 (fr
Inventor
Lilin Wang
Dan Smith
Bill Phillips
Adrian Bot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Multicell Immunotherapeutics Inc
Original Assignee
Multicell Immunotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multicell Immunotherapeutics Inc filed Critical Multicell Immunotherapeutics Inc
Publication of EP1937300A2 publication Critical patent/EP1937300A2/fr
Publication of EP1937300A4 publication Critical patent/EP1937300A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6056—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • C07K2318/10—Immunoglobulin or domain(s) thereof as scaffolds for inserted non-Ig peptide sequences, e.g. for vaccination purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP06801942A 2005-08-17 2006-08-17 Méthodes et compositions pour produire et contrôler le profil effecteur de lymphocytes t par chargement et activation simultanés de sous-ensembles sélectionnés de cellules présentatrices d'antigène Withdrawn EP1937300A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70898005P 2005-08-17 2005-08-17
PCT/US2006/032512 WO2007022477A2 (fr) 2005-08-17 2006-08-17 Méthodes et compositions pour produire et contrôler le profil effecteur de lymphocytes t par chargement et activation simultanés de sous-ensembles sélectionnés de cellules présentatrices d'antigène

Publications (2)

Publication Number Publication Date
EP1937300A2 EP1937300A2 (fr) 2008-07-02
EP1937300A4 true EP1937300A4 (fr) 2009-08-12

Family

ID=37758473

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06801942A Withdrawn EP1937300A4 (fr) 2005-08-17 2006-08-17 Méthodes et compositions pour produire et contrôler le profil effecteur de lymphocytes t par chargement et activation simultanés de sous-ensembles sélectionnés de cellules présentatrices d'antigène

Country Status (2)

Country Link
EP (1) EP1937300A4 (fr)
WO (1) WO2007022477A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438643B (zh) 2008-11-30 2015-07-01 免疫桑特公司 用于治疗乳糜泻的组合物和方法
WO2015038624A1 (fr) 2013-09-10 2015-03-19 Immusant, Inc. Dosage d'une composition peptidique de gluten
WO2016054038A1 (fr) 2014-09-29 2016-04-07 Immusant, Inc. Utilisation de statut génétique hla pour évaluer ou sélectionner un traitement de la maladie cœliaque
US10441649B2 (en) 2015-02-02 2019-10-15 The University Of Birmingham Targeting moiety peptide epitope complexes having a plurality of T-cell epitopes
GB2576914A (en) * 2018-09-06 2020-03-11 Kymab Ltd Antigen-binding molecules comprising unpaired variable domains produced in mammals
WO2024126758A2 (fr) 2022-12-14 2024-06-20 Ultimovacs Ab Molécule d'acide nucléique et polypeptide chimérique

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036087A1 (fr) * 1997-02-13 1998-08-20 American National Red Cross Tolerance immunologique aux epitopes du hiv
WO2004027049A2 (fr) * 2002-09-20 2004-04-01 Astral, Inc. Procedes et compositions pour generer et controler le profil effecteur de lymphocytes t par le chargement et l'activation de sous-ensembles selectionnes de cellules presentant l'antigene

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US6777546B2 (en) * 1997-10-07 2004-08-17 Loma Linda University Methods and substances for preventing and treating autoimmune disease
AU2001280934A1 (en) * 2000-07-28 2002-02-13 Alliance Pharmaceutical Corp. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
US6811785B2 (en) * 2001-05-07 2004-11-02 Mount Sinai School Of Medicine Of New York University Multivalent MHC class II—peptide chimeras

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036087A1 (fr) * 1997-02-13 1998-08-20 American National Red Cross Tolerance immunologique aux epitopes du hiv
WO2004027049A2 (fr) * 2002-09-20 2004-04-01 Astral, Inc. Procedes et compositions pour generer et controler le profil effecteur de lymphocytes t par le chargement et l'activation de sous-ensembles selectionnes de cellules presentant l'antigene

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BELL JAMES J ET AL: "Asymmetric restoration of T cell tolerance revealed by an "in trans" EAE model", FASEB JOURNAL, vol. 18, no. 4-5, 2004, & FASEB MEETING ON EXPERIMENTAL BIOLOGY: TRANSLATING THE GENOME; WASHINGTON, DISTRICT OF COLUMBIA, USA; APRIL 17-21, 2004, pages Abst. 563.7 URL - http://ww, XP009119304, ISSN: 0892-6638 *
LEGGE K L ET AL: "Multi-modal antigen specific therapy for autoimmunity", INTERNATIONAL REVIEWS OF IMMUNOLOGY, HARWOOD ACADEMIC PUBLISHERS, LONDON, GB, vol. 20, 1 January 2001 (2001-01-01), pages 593 - 611, XP002970594, ISSN: 0883-0185 *
MELO MARCO E F ET AL: "Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases.", JOURNAL OF IMMUNOLOGY, vol. 168, no. 9, 1 May 2002 (2002-05-01), pages 4788 - 4795, XP002535132, ISSN: 0022-1767 *
PHILLIPS WILLIAM J ET AL: "Recombinant immunoglobulin-based epitope delivery: A novel class of autoimmune regulators", INTERNATIONAL REVIEWS OF IMMUNOLOGY, vol. 24, no. 5-6, September 2005 (2005-09-01), pages 501 - 517, XP009119306, ISSN: 0883-0185 *
ZAGHOUANI HABIB ET AL: "Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 23, no. 11, 1993, pages 2746 - 2750, XP009119271, ISSN: 0014-2980 *
ZAMBIDIS E T ET AL: "EPITOPE-SPECIFIC TOLERANCE INDUCTION WITH AN ENGINEERED IMMUNOGLOBULIN", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC., US, vol. 93, 1 May 1996 (1996-05-01), pages 5019 - 5024, XP002911069, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2007022477A3 (fr) 2007-08-30
EP1937300A2 (fr) 2008-07-02
WO2007022477A2 (fr) 2007-02-22

Similar Documents

Publication Publication Date Title
EP1827604A4 (fr) Procedes et compositions pour l' immunotherapie adoptive
EP2502938A3 (fr) Anticorps et immuno-conjugués et utilisations associées
PL1974017T3 (pl) Środki i sposoby do wpływania na stabilność komórek wytwarzających przeciwciała
IL186765A0 (en) Method and bioreactor for producing synfuel from carbonaceous material
EP1697748A4 (fr) Methodes permettant de generer des molecules multimeres
EP1832187A4 (fr) Perruque et procede pour la produire
GB0508101D0 (en) Methods and apparatus for the manufacture of microstructures
EP1731261A4 (fr) Chaine verticale de travail pour materiau en plaque
EP1832188A4 (fr) Perruque et procede pour la produire
IL180546A0 (en) Novel piperidine derivative for the treatment of depression
EP1905795A4 (fr) Polysiloxane et procédé pour produire celui-ci
GB2429777B (en) Method and apparatus for controlling the acoustic output of an airgun
EP1937300A4 (fr) Méthodes et compositions pour produire et contrôler le profil effecteur de lymphocytes t par chargement et activation simultanés de sous-ensembles sélectionnés de cellules présentatrices d'antigène
FR2872592B1 (fr) Chaine amplificatrice pour la generation d'impulsions lumineuses ultracourtes de durees d'impulsions differentes
EP1854467A4 (fr) Composition pour l'activation immunitaire
GB0428136D0 (en) Novel materials and methods for the production thereof
DE112006000410B8 (de) Pfropf-Copolymer und Verfahren zum Herstellen desselben
GB2422842B (en) Process for the production of multipurpose energy sources and multipurpose energy sources produced by said process
GB0525567D0 (en) Novel materials and methods for the production thereof
EP1781337A4 (fr) Procedes et compositions pour l'activation de cellules
DE602005022712D1 (de) Fischer-tropsch-syntheseverfahren mit verbesserter steuerung
FI20041610A0 (fi) Menetelmä tuotantoyksikössä käytettävän rehun tuotannon ohjaamiseksi
EP1833955B8 (fr) Article plastifie pour traitement cutane
FR2905057B1 (fr) Plaque de presentation support d'outils
NO20070043L (no) Fremgangsmåte for behandling av Fischer-Tropsch-hydrokarboner

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080317

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WANG, LILIN

Inventor name: BOT, ADRIAN

Inventor name: PHILLIPS, BILL

Inventor name: SMITH, DAN

A4 Supplementary search report drawn up and despatched

Effective date: 20090715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091014